# Consensus Motif Analysis - Summary

**Date**: 2025-10-11  
**Status**: ✅ Complete  
**Analysis Script**: `scripts/data/splice_sites/analyze_consensus_motifs.py`

---

## What Was Done

### 1. Fixed Critical Bug in Coordinate Interpretation ✓

**Problem**: Initial implementation had incorrect coordinate handling for acceptor sites on negative strand, leading to only ~55% AG match (should be ~99.6%).

**Root Cause**: Misunderstanding of the `position` field in `splice_sites_enhanced.tsv`:
- **Acceptor sites**: `position` = first base of **exon** (after AG), not last base of intron
- **AG dinucleotide**: last 2 bases of **intron** at positions `[position-2, position-1]` (0-based)

**Solution**: Updated extraction logic in `extract_acceptor_motif()`:
- **Positive strand**: 
  ```python
  start = (position - 2) - intron_bases
  end = (position - 1) + exon_bases + 1
  ```
- **Negative strand**:
  ```python
  start = position - exon_bases - 1
  end = position + intron_bases + 1
  seq = reverse_complement(seq)
  ```

**Validation**: After fix, AG match = **99.63%** ✓

---

### 2. Full Dataset Analysis ✓

Analyzed all **2,829,398 splice sites** (1,414,699 donors + 1,414,699 acceptors) from `splice_sites_enhanced.tsv`.

#### Key Results:

**Donor Sites (9-mer: `NAG|GTAAGN`)**:
- Canonical GT at +1,+2: **98.51%**
- Non-canonical GC at +1,+2: **1.12%**
- Full MAG|GTRAGT match: **4.01%**
- Observed consensus: `NAG|GTAAGN`

**Acceptor Sites (25-mer: polypyrimidine + AG)**:
- AG dinucleotide at boundary: **99.63%**
- Average polypyrimidine content: **74.9%**
- Peak pyrimidine content (position -5): **84.5%**
- YAG motif distribution:
  - CAG: **63.4%**
  - TAG: **29.6%**
  - Combined CAG+TAG: **93.0%**

**Output**: `scripts/data/output/full_consensus_analysis.txt`

---

### 3. Comprehensive Documentation ✓

Created detailed markdown report: `docs/data/splice_sites/extended_consensus_motif_analysis.md`

**Contents**:
- Executive summary with key findings
- Detailed position-specific frequency tables
- Biological interpretation of each position
- Comparison with established literature
- Non-canonical splice site analysis
- Implications for MetaSpliceAI meta-models
- Complete methods and reproducibility section
- Future directions (branch point analysis, U12-type introns)
- Full references

---

### 4. Production-Ready Script ✓

Enhanced `analyze_consensus_motifs.py` with:
- Full argparse CLI with comprehensive options
- Help documentation with usage examples
- Sampling support (`--sample N` or `--full`)
- Output redirection (`--output FILE`)
- Verbosity control (`--verbose`, `--quiet`)
- Error handling and graceful interruption
- File validation

**Usage Examples**:
```bash
# Quick test (50k sample, default)
python scripts/data/splice_sites/analyze_consensus_motifs.py

# Full analysis
python scripts/data/splice_sites/analyze_consensus_motifs.py --full

# Specific chromosomes
python scripts/data/splice_sites/analyze_consensus_motifs.py --full --chromosomes 1 2 X Y

# Save to file
python scripts/data/splice_sites/analyze_consensus_motifs.py --full --output results.txt

# Get help
python scripts/data/splice_sites/analyze_consensus_motifs.py --help
```

---

## Biological Insights Confirmed

### Donor Sites (Exon|Intron Boundary)

✅ **GT-AG Rule**: 98.51% canonical GT donors  
✅ **GC-AG Introns**: 1.12% non-canonical GC donors (U2-type)  
✅ **Extended Context**: Strong position preferences at -1 (80% G), -2 (64% A), +3 (61% A), +4 (69% A), +5 (77% G)  
✅ **U1 snRNP Recognition**: Nearly absolute conservation at +1,+2 (GT)

### Acceptor Sites (Intron|Exon Boundary)

✅ **AG Invariance**: 99.63% AG at boundary  
✅ **Polypyrimidine Tract**: 74.9% average C+T content, increasing toward boundary (peaks at position -5: 84.5%)  
✅ **YAG Preference**: 93% have pyrimidine (C or T) at position -1  
✅ **U2AF65 Binding**: Polypyrimidine tract provides essential recognition signal  
✅ **Branch Point Region**: Clear gradient in pyrimidine enrichment upstream of AG

---

## Key Coordinate System Clarification

**Critical Understanding** (confirmed through debugging):

**Donor Sites**:
- `position` field = **first base of intron** (the G in GT)
- GT dinucleotide = positions `[position, position+1]` (1-based) = first 2 bases of intron
- Extraction: `...exon]GT[intron...`

**Acceptor Sites**:
- `position` field = **first base of exon** (after the AG)
- AG dinucleotide = positions `[position-1, position]` (1-based) = last 2 bases of intron
- Extraction: `...intron]AG[exon...`

This distinction is **critical** for correct sequence extraction, especially on negative strand.

---

## Files Generated

1. **Analysis Script** (production-ready):
   - `scripts/data/splice_sites/analyze_consensus_motifs.py`

2. **Full Analysis Output**:
   - `scripts/data/output/full_consensus_analysis.txt`

3. **Documentation**:
   - `docs/data/splice_sites/extended_consensus_motif_analysis.md` (comprehensive)
   - `docs/data/splice_sites/CONSENSUS_ANALYSIS_SUMMARY.md` (this file)
   - `docs/data/splice_sites/consensus_dinucleotide_analysis.md` (previous)
   - `docs/data/splice_sites/enhanced_splice_site_annotations.md` (enhanced TSV spec)

---

## Implications for MetaSpliceAI

### Feature Engineering

The meta-model should incorporate:

1. **Extended donor score** (positions -3 to +6, not just GT)
2. **Polypyrimidine tract strength** (positions -20 to -3 for acceptors)
3. **YAG motif bonus** (CAG > TAG > AAG for acceptors)
4. **Position-specific log-odds** based on observed frequencies
5. **Non-canonical site flags** (GC-AG introns, rare acceptors)

### Variant Impact Prediction

When predicting cryptic splice sites:

1. **Donor creation**: Prioritize GT (or GC) + extended context (MAG|GTAAGN)
2. **Acceptor creation**: Prioritize AG + upstream polypyrimidine tract + YAG motif
3. **Site disruption**: GT→GC (moderate), GT→other (severe), AG→other (severe)
4. **Context weakening**: Loss of polypyrimidine tract, suboptimal extended donor

### Base Model Recalibration

Use extended consensus to:
- **Boost** predictions for sites with strong extended context
- **Penalize** predictions with weak/atypical context
- **Distinguish** true sites from false positives
- **Identify** cryptic sites with non-canonical but functional patterns

---

## Future Work (Optional)

The analysis is complete, but future enhancements could include:

1. **Branch Point Analysis**: Extend acceptor motif to 50-mer, search for YRAY/YURAY motifs
2. **U12-Type Introns**: Separate analysis of AT-AC introns (<0.5%)
3. **Tissue/Context Specificity**: Compare constitutive vs alternative splice sites
4. **ESE/ISS Motifs**: Hexamer enrichment near splice sites
5. **RNA Structure**: Predicted secondary structure influence

These are tracked in TODO: `todo-7` (pending).

---

## Testing and Validation

✅ **Coordinate System**: Validated with manual IGV inspection  
✅ **Strand Handling**: Separate validation for + and - strands  
✅ **Consistency**: Results match previous dinucleotide analysis (99.63% AG)  
✅ **Sample Size**: 50k sample sufficient for ±0.1% precision  
✅ **Full Dataset**: Final analysis on all 2.8M sites for maximum precision  
✅ **CLI Functionality**: Tested with multiple argument combinations  

---

## How to Reproduce

```bash
# Activate environment
mamba activate surveyor

# Change to project root
cd /Users/pleiadian53/work/meta-spliceai

# Run full analysis (takes ~5-10 minutes)
python scripts/data/splice_sites/analyze_consensus_motifs.py --full

# Or run quick test (50k sample, takes ~30 seconds)
python scripts/data/splice_sites/analyze_consensus_motifs.py --sample 50000

# Save output to file
python scripts/data/splice_sites/analyze_consensus_motifs.py --full \
    --output scripts/data/output/consensus_analysis_$(date +%Y%m%d).txt
```

---

## Status: ✅ All Tasks Complete

- [x] Step 1: Run full analysis on all 2.8M sites
- [x] Step 2: Generate comprehensive markdown report
- [x] Step 3: Add CLI args and make script production-ready

**Total Runtime**: ~10 minutes for full analysis  
**Result Quality**: High-fidelity statistics matching expected biological patterns  
**Reproducibility**: Fully documented with methods, validation, and examples

---

**Document Version**: 1.0  
**Last Updated**: 2025-10-11  
**Next Steps**: Optional branch point and non-canonical intron analysis (todo-7)

